the aid library

Guidelines on advanced practice nursing: nurse anesthetists

International council of Nurses (2021) C1

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2019–2020

European Centre for Disease Prevention and Control ECDC (2022) CC

This report provides an overview of the main findings of the 2019–2020 harmonised AMR monitoring in the main food-producing animal populations monitored, in carcase/meat samples and in humans. Where available, monitoring data obtained from pigs, calves, broilers, laying hens and turkeys, as well a ... more

Global medication waste management practices: challenges and opportunities in developing countries

Bataduwaarachchi, V.R.; and C.L.Weeraratne (2016) CC

International Journal of Basic & Clinical Pharmacology 5(6):2290-2294 DOI: 10.18203/2319-2003.ijbcp20164081

The burden of chronic respiratory diseases and their heterogeneity across the states of India: the Global Burden of Disease Study 1990–2016

India State-Level Disease Burden Initiative CRD Collaborators (2018) CC

Lancet Glob Health 2018 Published Online September 12, 2018 http://dx.doi.org/10.1016/S2214-109X(18)30409-1

WHO mission on ART optimization in Belarus March 30-31, April 1, 2016

M. Ristola; V. Rusovich; J. Lundgren; S. F. Jakobsen World Health Organization (Europe); WHO Collaborating Centre on HIV and Viral Hepatitis (2016) C2

April, 2016

Electronic Tools. Technical Series on Safer Primary Care

World Health Organization WHO (2016) C_WHO

Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis

World Health Organization WHO (2012) C_WHO

This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re ... more

Treating Buruli Ulcer

Médecines sans Frontièrs MSF (2013) CC

A review of prospects for existing antibiotics ad new therapeutics

Role of anticholinergic medications in patients requiring long-term antipsychotic treatment for psychotic disorders

World Health Organization WHO (2012) C_WHO

Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adherence than placebo/treatment as usual?

Guide pour les services de fauteuils roulants manuels dans les régions à faibles revenus

Organisation Mondiale de la Santé OMS; USAID; ISPO World Health Organisation (WHO) (2008) C_WHO

Recommendations for Inactivated Rabies Vaccine for Human Use Produced in Cell Substrates and Embryonated Eggs

WHO WHO (2005)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ... and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Aktualisierung der Meningokokken-Impfempfehlung: Anwendung des Meningokokken-B-Impfstoffs bei Personen mit erhöhtem Risiko für Meningokokken-Erkrankungen

Robert-Koch-Institut RKI (2015) C1